Pfizer To Resolve Asbestos Claims On Quigley and 2 Other Dow Movers To Watch

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Pfizer (NYSE:PFE): Current price $28.33

On Wednesday, the bankruptcy Judge Stuart Bernstein in Manhattan approved a Chapter 11 plan that will permit Pfizer’s non-operating Quigley Co. to end nearly nine years in bankruptcy, resolving the majority of asbestos claims against the company and its defunct unit. Under the settlement’s terms, Pfizer will contribute assets worth $964 million. Bernstein turned aside a prior plan almost three years ago, deciding that Pfizer was improperly making use of Quigley’s bankruptcy to shield itself from asbestos claims. Then in September 2010, the judge found that Pfizer’s proposed $216.2 million contribution to a previous plan insufficient, considering court testimony that Quigley could face $4.45 billion in claims over 42 years, and that asbestos claimants might have come out better by suing the company under civil tort law.


More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business